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Abstract
Background: In managing a life with coronary heart disease and the possibility of planning and following a
rehabilitation plan, patients’ empowerment and self-efficacy are considered important. However, currently there is
limited data on levels of empowerment among patients with coronary heart disease, and demographic and clinical
characteristics associated with patient empowerment are not known.
The purpose of this study was to assess the level of patient empowerment and general self-efficacy in patients six
to 12 months after the cardiac event. We also aimed to explore the relationship between patient empowerment,
general self-efficacy and other related factors such as quality of life and demographic variables.
Methods: A sample of 157 cardiac patients (78% male; age 68 ± 8.5 years) was recruited from a Swedish hospital.
Patient empowerment was assessed using the SWE-CES-10. Additional data was collected on general self-efficacy
and well-being (EQ5D and Ladder of Life). Demographic and clinical variables were collected from medical records
and interviews.
Results: The mean levels of patient empowerment and general self-efficacy on a 0–4 scale were 3.69 (±0.54) and
3.13 (±0.52) respectively, and the relationship between patient empowerment and general self-efficacy was weak
(r = 0.38). In a simple linear regression, patient empowerment and general self-efficacy were significantly correlated
with marital status, current self-rated health and future well-being. Multiple linear regressions on patient empowerment
(Model 1) and general self-efficacy (Model 2) showed an independent significant association between patient
empowerment and current self-rated health. General self-efficacy was not independently associated with any of the
variables.
Conclusions: Patients with a diagnosis of coronary heart disease reported high levels of empowerment and general
self-efficacy at six to 12 months after the event. Clinical and demographic variables were not independently associated
with empowerment or low general self-efficacy. Patient empowerment and general self-efficacy were not mutually
interchangeable, and therefore both need to be measured when planning for secondary prevention in primary health
care.
Trial registration: NCT01462799.
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Background
Coronary heart disease is the major cause of premature
death among men and women in Europe [1]. Yearly,
around 30,000 Swedes suffer a myocardial infarction [2]
and among patients who survive, about 20% suffer a sec-
ondary cardiovascular event in the first year. Around
50% of major coronary events occur among those with a
previous diagnosis of myocardial infarction [3]. Regular
exercise, smoking cessation and the use of cardiovascu-
lar preventive drugs are effective preventive actions that
reduce mortality and re-infarction rates [4]. Yet, risk fac-
tors remain significant in patients, even after initiation
of secondary prevention. A study of patients with coron-
ary heart disease showed that 48.6% continued to smoke
1.35 years in median time after the cardiovascular event,
almost two out of three patients were physically inactive,
38% were obese, more than 40% had hypertension and
80.5% had hypercholesterolemia [5].
Cardiac rehabilitation and secondary prevention,
which are confirmed to be effective and safe in the man-
agement of clinically stable patients with coronary heart
disease, are two other kinds of support accessible during
the recovery process. Therefore, it is problematic that
only 20–50% of the eligible patients [6] attend cardiac
rehabilitation programmes that could facilitate smoking
cessation and taking up physical exercise, which are
really effective preventive actions [7] that reduce mortal-
ity after myocardial infarction [8, 9].
For patients recovering from a myocardial infarction,
restenosis after percutaneous coronary intervention, or
coronary artery bypass surgery, achieving control of their
own health has been viewed as a struggle, including ne-
gotiating the management of daily problems [10]. Bodily
experiences make cardiac patients uncertain and fright-
ened of recurrence and death. Patients’ questions about
how long the effects of the cardiac surgery will last also
demonstrate their uncertainty. It seems that after revas-
cularisation, patients are not always aware that they are
chronically ill, and this may have consequences for the
management and practice of self-care [11]. Additionally,
patients experience, for example, constraining somatic
and social incentives, affecting their capacity to perform
physical activity and to follow programmes of drug treat-
ment [12]. If patients felt safe and in control based on
their understanding of their heart disease during cardiac
rehabilitation and were inclined to manage self-care with
support, their recovery could proceed more smoothly.
Patients’ recovery after coronary heart disease seems
complex and challenging, and we need to know more
about key factors that facilitate this recovery.
Patient empowerment (PE) is viewed as a key factor for
improving health outcomes, enhancing communication
between patients and health professionals, bringing about
better adherence to treatment regimes, and ensuring the
efficient use of primary health resources. This is outlined
as a specific intention by the World Health Organization’s
(WHO) Regional Office for Europe in Health 2020 [13].
According to this policy framework, which provides main
strategies and priorities to support European action for
health and well-being, people are increasingly seen as co-
producers of their own health, and need to be empowered
to take control of the determinants of their own health
[13]. The WHO defines PE as a process where patients
understand their role, are given the knowledge and skills
by the health care provider to perform a task in an envir-
onment where there is an awareness of community and
cultural differences, and where patients are encouraged to
participate [14]. A recent concept analysis of PE stated
that:
“Individual patient empowerment is a process that
enables patients to exert more influence over their
individual health by increasing their capacities to gain
more control over issues they themselves define as
important [15] (p. 1927).”
Moreover, Castro et al. [15] found that PE is situated
on several levels (micro-, meso- and macro-) and could
be approached by the patient, the health care provider
or the health care system.
Self-efficacy (SE), a concept derived from social cogni-
tive theory, concerns people’s beliefs in their capacity to
exercise control over events that affect their lives [16].
SE beliefs influence how people think, feel, motivate
themselves and act [17]. It has been viewed as relevant
in relation to the fact that people and populations who
believe they will succeed are more likely to attempt a
new behaviour. To achieve SE, a person might perform a
task that was previously successful within their capabil-
ities (mastery experience), watch someone with whom
they can identify performing a task successfully (social
modelling), receive positive feedback/verbal persuasion
relating to the task from someone or interpret physio-
logical or affective states, with some or all of these fac-
tors being present before SE is accomplished [18]. SE is
a well-studied concept within cardiac rehabilitation. Re-
lationships between perceived SE [19] and personal goals
during cardiac rehabilitation have been positively associ-
ated with physical exercise six and 12 months after dis-
charge [20], with food choices after a tailored one-year
intervention at an outpatient clinic [21], with smoking
habits two to four weeks after discharge [22], and with
health-related quality of life two years post-MI [23].
General SE (GSE) has received attention in research, and
it is defined as the belief in one’s competence to cope
with a broad range of stressful and challenging demands.
GSE appears to be a universal construct yielding mean-
ingful relations with other psychological constructs and
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having a positive impact on health behaviours [24]. Pa-
tients with high GSE recovered better one week after
cardiac surgery and experienced a higher quality of life
six months later compared with their low-GSE counter-
parts [25]. Thus, it is important to consider GSE when
predicting behavioural intentions and health behaviour
change after an event of coronary heart disease.
We argue that GSE and PE are important to consider
at an individual level, for managing life with coronary
heart disease, as well as at an organisational level, for ar-
ranging secondary cardiac rehabilitation in primary
health care. However, PE is not well-studied in cardiac
rehabilitation.
We therefore assessed the level of GSE and PE in pa-
tients who had been diagnosed with coronary heart dis-
ease six to 12 months ago. Based on previous literature
and theoretical foundation we also explored the relation
between other related factors such as gender, age marital
status, education, well-being, self-rated health, cardio-
vascular risk factors and diseases, in relation to PE and
GSE.
Methods
Setting
In this cross-sectional study, we recruited patients with
coronary heart disease in south-east Sweden between
September 2011 and November 2014. A detailed de-
scription of the study procedures is given in a design art-
icle [26], but a summary is provided below.
Recruitment
The patients were invited to the COR-PRIM study, an
ongoing five-year prospective single- centre randomised
controlled study (NCT01462799), performed in a pri-
mary health care setting in south-eastern Sweden. The
current analysis uses the baseline data of the patients.
The recruitment was conducted by the Vrinnevi Hos-
pital heart unit in Norrköping, Sweden, from the elec-
tronic medical record, based on the following criteria:
Inclusion criteria were: (i) patients with coronary heart
disease verified by myocardial infarction and/or percu-
taneous coronary intervention and/or coronary artery
bypass surgery six to 12 months before the planned start
of the interventions, (ii) patients who were stable regard-
ing their cardiac condition and taking optimised cardiac
medication that had not substantially changed during
the previous month, (iii) patients who had completed
heart school in hospital, and were listed at one of six
specific primary health care centres. Exclusion criteria
were: planned coronary artery bypass surgery or other
conditions demanding continuing cardiologic care; for
example: ongoing contact with heart failure clinic due to
drug titration, life expectancy ≤ one year, documented
psychiatric disease causing difficulties in cooperating with
other people, obvious abuse of alcohol or narcotics. Pa-
tients were also excluded if they were unable to read or
communicate in the Swedish language.
The patients were informed about the study during a
visit to a nurse. The nurse asked the patients if the re-
searcher in charge of the project could contact them by
letter and telephone call in order to further inform them
and discuss possible recruitment with them. Of 446 pa-
tients invited, 157 consented to participate (response
rate 35%), completed and sent back questionnaires at
baseline before randomisation and before any interven-
tion was started (Fig. 1).
Patient questionnaires
Patient empowerment was assessed by the SWE-CES-10
questionnaire, which was developed to survey PE in pa-
tients with coronary heart disease. This questionnaire
was originally based on the SWE-DES-23, which is a
valid and reliable tool for assessing PE in diabetes melli-
tus (DM) and rheumatic disease (RA) [27–29]. The
SWE-DES-23 was shortened to become the SWE-DES-
SF-10 and was found to be reliable in relation to the ori-
ginal version. The author of the scale allowed us to re-
place the word ‘diabetes’ with ‘heart disease’ in all 10
items and agreed that further psychometric testing was
not needed before using the scale in patients with car-
diac disease. The SWE-CES-10 has four subscales asses-
sing different components of patient empowerment: 1)
Goal achievement and overcoming barriers to goal
achievement, 2) Self-awareness, 3) Managing stress, 4)
Assessing dissatisfaction and readiness to change. The
items are scored on a five-point Likert scale ranging
from ‘strongly disagree’ (1) to ‘strongly agree’ (5). A
higher value indicates a stronger empowerment [30].
Self-efficacy was assessed by the General Self-Efficacy
Scale (GSES, Additional file 1) [31], on which items are
scored on a four-point Likert scale ranging from ‘not at
all true’ (1) to ‘exactly true’ (4). A higher score indicates
a higher GSE, which predicts the ability to cope with
daily problems and the ability to adapt after experiencing
various stressful life events [32]. High reliability, stability
and construct validity of the GSES scale are confirmed
in earlier studies [33, 34].
Well-being was assessed by the Cantril Ladder, a
single-item indicator of well-being. This scale is pre-
sented as a ladder with steps numbered from zero at the
bottom to 10 at the top, where 10 represents the best
possible life for the participant, and zero the worst. The
participants are asked on which step of the ladder they
feel they stood one year ago, on which step they stand at
present, and on which step they will stand one year in
the future. The Ladder of Life has been used in large
population studies, and tested for reliability, concurrent
and predictive validity [35]. It has also been used in
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elderly patients recovering from an acute coronary event
[36] and in a randomised study of patients with coronary
heart disease [37].
Self-rated health was measured by the Visual Analogue
Scale within the EQ5D (Additional file 2). It produces
scores of 0–100, with higher scores indicating a better
overall quality of life [38].The EQ5D is considered to be
a reliable and valid instrument for use in patients with
stable coronary heart disease [39].
Demographic and clinical data
Patients’ baseline data on: type of cardiovascular event,
days of treatment of hypertension and hyperlipidaemia,
smoking, presence of comorbidities (DM, hypertension,
chronic obstructive pulmonary disease, stroke, heart fail-
ure) were collected from the Swedeheart® register and
the medical records about two weeks after discharge
from the hospital. Age, sex, education, residential area,
job position and marital status were collected from pa-
tient questionnaires (Table 1). The patients were also
asked to self-report, in free text their diseases. Cardio-
vascular diseases and DM were excluded. Self-reported
comorbidity was categorised by the researchers as: co-
morbidities of all kinds or comorbidity affecting mobil-
ity. This was done in order to catch the total experience
of burden of disease.
Statistical analyses
Descriptive statistics were used to characterise the study
population. Means, medians and standard deviations are
presented for patients’ baseline data involving clinical
and demographical measures. Chi-square tests were used
Patients (n= 446) invited to
participate in the study by nurse 
at an outpatient clinic.
Written informed consent 
obtained, returned base-line 
questionnaire.
Included n=157 (35%)
Contacted by researcher via 
letter and telephone n=446
No response n=20
Not meeting the inclusion 
criteria n=23
Excluded due to:
Other project: 5
Wrong PHC centre: 2
Difficulties cooperating: 7
Planned intervention: 4
Not Swedish speaker: 2 
No informed consent: 3
Declined to participate n=246
Fig. 1 Sampling frame
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Table 1 Baseline characteristics of patients suffering from a coronary heart disease event 6–12 months ago. Comparison of self-
reported high or low patient empowerment (SWE-CES-101) and general self-efficacy (GSESa)
Total n = 157
n (%), mean
(SD)
SWE-CES-
10 ≤ 3.6
n = 77
n (%), mean
(SD)
SWE-CES-10 > 3.6 n
= 72
n (%), mean (SD)
p-
value
GSES≤ 2.95
n = 48
n (%), mean
(SD)
GSES > 2.95
n = 98
n (%), mean
(SD)
p-
value
Gender, M/F 122/35 58/19 58/14 0.442 36/12 76/22 0.732
Age, years 68.7 (8.5) 68.4 (8.6) 68.7 (8.4) 0.828 68.7 68.8 0.919
Residential area
City 74 (47.1) 39 (50.6) 30 (41.7) 24 (50.0) 43 (43.9)
Rural or small town 83 (52.9) 38 (49.4) 42 (48.3) 0.272 24 (50.0) 55 (56.1) 0.486
Education
Compulsory educationb 84 (53.5) 40 (51.9) 39 (54.2) 25 (52.1) 54 (55.1)
Upper secondary school 31 (19.7) 14 (18.2) 16 (22.2) 10 (20.8) 20 (20.4)
University 38 (24.2) 21 (27.3) 17 (23.6) 0.493 13 (27.1) 23 (23.5) 0.869
Job position
Employed 26 (16.9) 10 (13.0) 16 (22.2) 9 (18.8) 15 (15.3)
Self-employed 15 (9.7) 10 (13.0) 5 (6.9) 4 (8.3) 10 (10.2)
Disabled pensioner 9 (5.8) 6 (7.8) 3 (4.2) 5 (10.4) 4 (4.1)
Retired pensioner 104 (67.5) 50 (64.9) 48 (66.7) 0.295 30 (62.5) 68 (69.4) 0.531
Marital status
Cohabitating 115 (73.2) 53 (68.8) 59 (81.9) 33 (68.8) 75 (76.5)
Living alone 40 (25.5) 24 (31.2) 13 (18.1) 0.064 15 (31.3) 23 (23.5) 0.314
Time from cardiac event to start of study group,
days
284 (74) 274 (75) 291 (70) 0.147 277 (67) 289 (78) 0.362
Smoking, current 19 (12.1) 10 (13.0) 8 (11.1) 0.726 7 (14.6) 10 (10.2) 0.438
Cardiac event one year before study inclusionc
Myocardial infarction 86 (54.8) 43 (55.8) 41 (56.9) 25 (52.1) 56 (57.1)
Other 71 (45.2) 34 (44.2) 31 (43.1) 0.892 23 (47.9) 42 (42.9) 0.563
Cardiac event one year before study inclusion
PCI only 110 (70.1) 55 (71.4) 50 (69.4) 34 (70.8) 68 (69.4)
CABG, CABG+PCI or MI without
revascularisation
47(29.9) 22 (28.6) 22 (30.6) 0.791 14 (29.2) 30 (30.6) 0.858
Number of previous myocardial infarctions
1 15 (10.1) 9 (11.7) 6 (8.3) 4 (8.3) 8 (8.2)
2 3 (2.0) 1 (1.3) 2 (2.8) 2 (4.2) 1 (1.0)
3 2 (1.3) 1 (1.3) 1 (1.4) 0.841 0 (0) 2 (2.0) 0.468
Angina pectoris, diagnosed 47 (29.9) 26 (33.8) 19 (26.4) 0.327 17 (35.4) 28 (28.6) 0.400
CCSd
I 98 (62.4) 53 (75.7) 41 (64.1) 26(61.9) 66 (73.3)
II 27 (17.2) 9 (12.9) 16 (25.0) 9 (21.4) 17 (18.9)
III 11 (7.0) 6 (8.6) 5 (7.8) 5 (11.9) 5 (5.6)
IV 4 (2.5) 2 (2.9) 2 (3.1) 0.345 2 (4.8) 2 (2.2) 0.430
Diabetes Mellitus 25 (15.9) 9 (11.7) 14 (19.4) 0.190 11 (22.9) 13 (13.3) 0.139
Hypertension 75 (47.8) 37 (48.1) 36 (50.0) 0.812 26 (54.2) 47 (48.0) 0.481
Medication for hypertension before study start,
days
1376 (649–
2094)e
1542 (673–
2107)e
1270 (645–1883)e 0.383 1459 (649–
2149)e
1187 (649–
1912)e
0.641
COPDf 15 (9.6) 9 (11.7) 6 (8.3) 0.496 5 (10.3) 9 (9.2) 0.812
Kärner Köhler et al. BMC Family Practice  (2018) 19:76 Page 5 of 10
to compare dichotomised variables. The SWE-CES-10 (Pa-
tient Empowerment Scale) was dichotomised based on the
median value in the present sample (md = 3.6). For GSES
(Additional file 1), the mean value for population data [40]
was used as a cut-off value (m = 2.95) when dichotomised.
Simple linear and multiple regression models were used
where the two main outcome variables, GSES and PE, were
considered dependent. In order not to overlook effects, the
SWE-CES-10 and GSES variables were used as continuous
variables in multiple linear regression analysis (Model 1
and 2). Simple linear regressions tested the association of
PE and GSES with sex, age, marital status, education, well-
being (Cantril’s Ladder) and self-rated health (EQ5D). The
significant variables from the simple linear regressions, to-
gether with sex and age, were used in Models 1 and 2. A p-
value < 0.05 was considered significant.
Results
Of the individuals included, three quarters were men, and
the mean age for the whole group was 68.7 (±8.5) (range
47–87) years (Table 1). There were equal proportions living
in rural or small town areas or in the city. Half of the group
(54.8%) had suffered a myocardial infarction, and 70.1% of
all participants had been treated with percutaneous coron-
ary intervention. Twenty participants had had a previous
myocardial infarction. In total, 29.9% of the participants
had been diagnosed with angina pectoris, with 2.5% hav-
ing severe angina (CCS IV). The mean value for the par-
ticipants’ (n = 149) self-rated total PE was 3.69 (±0.54)
(theoretical range 1 low and 5 high). Mean values for sub-
scales were: Goal achievement 3.76 (±0.65), Self-
awareness 3.90 (±0.99), Managing stress 3.47 (±0.86),
Readiness to change 3.57 (±0.76). The mean value for
GSES was 3.13 (±0.52) (n = 146). Distributions are shown
in Figs. 2 and 3.
The correlation between the SWE-CES and GSES was,
r = 0.381 (p < 0.000). When SWE-CES and GSES were
dichotomised, there were no significant differences be-
tween participants rating high or low on these variables,
with the exception of hyperlipidaemia and GSE (Table 1).
Table 1 Baseline characteristics of patients suffering from a coronary heart disease event 6–12 months ago. Comparison of self-
reported high or low patient empowerment (SWE-CES-101) and general self-efficacy (GSESa) (Continued)
Total n = 157
n (%), mean
(SD)
SWE-CES-
10 ≤ 3.6
n = 77
n (%), mean
(SD)
SWE-CES-10 > 3.6 n
= 72
n (%), mean (SD)
p-
value
GSES≤ 2.95
n = 48
n (%), mean
(SD)
GSES > 2.95
n = 98
n (%), mean
(SD)
p-
value
Hyperlipidaemia 56 (35.7) 31 (40.3) 24 (33.3) 0.381 23 (47.9) 29 (29.6) 0.030
Days with treatment for hyperlipidaemia before
study start
1038 (420–
1884)e
695 (338–
2156)e
1150(507–1799)e 0.513 1061 (341–
1740)e
1067 (456–
2038)e
0.324
Comorbidity, all kinds 60 (38.2) 26 (33.8) 31 (43.1) 0.244 16 (33.3) 40 (40.8) 0.382
Comorbidity, affecting mobility 17 (10.8) 10 (13.0) 7 (9.7) 0.531 6 (12.5) 9 (9.2) 0.535
aDichotomized
bLess than 10 years in school
cCurrent, basis for study inclusion
dCanadian Cardiovascular Society scale for grading angina pectoris
eMedian (IQR)
fChronic obstructive pulmonary disease
Fig. 2 Distribution of empowerment SWE-CES. Scale 1–5 (n = 150)
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Patient empowerment, general self-efficacy and related
variables
Gender, age, marital status, education, self-rated health and
well-being were considered to be possibly related to PE. All
of these variables were first tested with simple linear regres-
sion. The variables that were significantly related to PE, to-
gether with gender and age, were used in the multiple
linear regression model. Consequently, the variable ‘educa-
tion’ was excluded from Model 1. The same procedures as
applied in PE were used when analysing GSES. There were
significant correlations between PE and marital status, self-
rated health (EQ5D) and well-being (Ladder of Life) in a
simple linear regression. In the multiple linear regression,
Model 1, the association between PE and self-rated health
(EQ5D) remained significant (Table 2). For GSE, there were
significant univariate correlations for all variables except
age and education. We excluded education in the mul-
tiple linear model. In the multiple linear regression,
Model 2, none of the variables were significantly associ-
ated with GSE (Table 3).
Discussion
This is the first study assessing PE and GSE and related var-
iables in a cardiac population. The levels of GSE and PE
were high, and GSE in this group was similar when com-
pared to a general population [40, 41] as well as for patients
with other chronic illnesses [34]. This might indicate that
levels of PE or GSE are not related to chronic conditions.
The main message of this study is that we were not able
to find demographic and clinical variables that could be
used as predictors of low PE or GSE. We cannot predict
how patients with coronary heart disease rate PE or GSE
based on variables such as age, sex, marital status, or type
of cardiovascular event. We found a significant association
between self-rated health and PE. The higher the patients
rated their health, the higher the PE. However, self-rated
health was not related to GSE. Our findings do not support
the hypothesis of Bravo et al. (2015), who suggested that
patients scoring high for PE would have better reported
outcomes, e.g. be better adapted to their condition; have
better quality of life; report higher levels of well-being and
Fig. 3 Distribution of self-efficacy. Scale 1–4 (n = 144)
Table 2 Simple and multiple correlation for patient empowerment (SWE-CES-10a). R2 0.125, adjusted R2 0.091
Simple linear regression Multiple linear regression
Independent variables Unstandardized Beta
coefficient
95% CI p-
value
Unstandardized Beta
coefficient
95% CI p-
value
Gender, M2/F −0.174 −
0.382
0.034 0.100 −0.92 −
0.302
0.119 0.392
Age, years 0.004 −0.007 0.014 0.474 0.008 −0.002 0.018 0.114
Education −0.016 −0.115 0.082 0.743 NA NA NA NA
Cohabitatingb/ Living alone 0.201 −0.400 −0.003 0.047 −0.088 −
0.295
0.120 0.405
Current self-rated health (scale 0–
100)c
0.010 0.005 0.014 <
0.001
0.007 0.002 0.013 0.014
Well-being (scale 0–10)d 0.060 0.014 0.106 0.011 0.021 −0.035 0.076 0.463
aContinuous variable, bReference, c EQ5D, d Ladder of life, NA Not applicable
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satisfaction with life and achieve some independence in re-
lation to their health care [42].
The mean level of PE in total did not differ from other
studies on chronic diseases, such as rheumatoid arthritis
(RA) [43] and DM [28]. On some of the subscales of PE,
the cardiac population scored higher compared to RA
on self-awareness (3.90) vs (3.5) and lower compared to
RA/DM on readiness to change (3.57) vs. (3.7); higher
compared to DM on goal- achievement (3.76) vs (3.64)
[28, 43]. An interpretation of this finding could be that
the cardiac population know enough for making self-
care choices, and when and where to get support if
needed. They are goal- oriented and can over-come bar-
riers to reach the goals. However, part of the self-care
causes dissatisfaction and to some extent they are cau-
tiously awaiting self-care change. This might be due to
lack of motivation despite them being knowledgeable.
According to the literature review [18], few studies
have investigated the connection between SE and PE.
We found a weak correlation between PE and GSE, indi-
cating that these cannot replace each other. GSE was
not related to educational level, civil status or well-
being, either. It is vital for people to acquire SE in order
to be able to handle adversity and the struggles they en-
counter in life [17]. We therefore argue that it is import-
ant to identify patients with low GSE and PE, as this
might place them at risk of failing to reach goals in their
cardiac rehabilitation plan. By measuring PE and GSE,
we can identify the patients that are in need of support
during cardiac rehabilitation. As addressed by WHO, PE
is a key factor for improving health outcomes, enhancing
communication between patients and health profes-
sionals, and adherence to treatment regimens [13].
There is a paradigm shift taking place, as clinical en-
counters have traditionally focussed on persuading pa-
tients to comply with taking medication as prescribed
[44], and PE is aiming instead at a collaboration between
health care professionals and patients, assisting the latter
in becoming self-aware of the considerations, needs and
barriers to changing their lifestyle, managing their ill-
ness, and using resources to solve problems in their daily
lives [45]. There is convincing evidence that
empowerment-based self-management interventions can
improve PE and also health outcomes. For example, PE
was significantly stronger among people with RA dis-
eases after problem-based learning programmes com-
pared to a control group six months post-intervention
[43]. A meta-analysis of empowerment-based interven-
tions showed improvements in HbA1C, SE and em-
powerment levels in patients with chronic metabolic
diseases [46]. Such interventions can be designed to fa-
cilitate patients’ self-management, and PE is also consid-
ered as a valuable measurable patient-reported outcome
for depression, DM and asthma [47, 48] and, among sur-
vivors from cancer, using information technology to im-
prove PE [49]. However, further randomised trials are
needed to evaluate the effects of interventions aimed at
improving GSE and PE to change/manage self-care. Lon-
gitudinal trials could help us to define at what scores
additional support is warranted [26].
Strengths and limitations
The present study has some limitations. Firstly, we used
cross-sectional data that was collected during an inter-
vention study. However, despite this shortcoming, this is
to our knowledge the first study that has investigated PE
in patients with coronary heart disease.
Secondly, we were unable to include more than half of
the invited patients in the study. Some gave reasons such
as feeling too old, living abroad for half of the year, diffi-
culties in travelling to the group meetings, or social cir-
cumstances, but we did not structurally collect data on
the non-participants, as in accordance with ethical legis-
lation, reasons for non-participation could not be col-
lected. We cannot therefore say whether the participants
differ significantly from the non-participants. In total,
35% of eligible patients were enrolled and that may be
considered as a small number, and as highly selected, as
Table 3 Simple and multiple correlation for dependent variable general self-efficacy (GSESa). R2 0.111, adjusted R2 0.076
Simple linear regression Multiple linear regression
Independent variables Unstandardised Beta
coefficient
95% CI p-
value
Unstandardised Beta
coefficient
95% CI p-
value
Gender, M2/F −0.202 −0.0399 −
0.005
0.045 − 0.145 −0.350 0.061 0.166
Age, years 0.000 −0.010 0.010 0.960 0.005 −0.006 0.015 0.371
Education 0.024 −0.074 0.123 0.628 NA NA NA NA
Cohabitatingb/ Living alone −0.246 −0.434 −
0.057
0.011 − 0.111 −0.317 0.095 0.288
Current self-rated health (scale 0–
100)c
0.008 0.004 0.013 <
0.001
0.004 −0.002 0.010 0.178
Well-being (scale 0–10)d 0.065 0.021 0.109 0.004 0.040 −0.015 0.095 0.149
aContinuous variable, bReference, c EQ5D, d Ladder of life, NA Not applicable
Kärner Köhler et al. BMC Family Practice  (2018) 19:76 Page 8 of 10
they from the start were positive and wanted to take part
in the COR-PRIM-study [26], which is quite a demand-
ing programme, with group discussions in primary care
over a period of one year and a long follow-up time of
five years. Internal drop-outs were low, and in compari-
son with Jelinek et al. [6] who enrolled 20–50% of eli-
gible patients to cardiac rehabilitation, the number of
participants in our study is not low.
Conclusion
PE and GSE are not mutually interchangeable, and
therefore both need to be measured when planning for
secondary prevention in primary health care. The results
showed that we cannot predict a high-risk group based
on demographic variables, e.g. patients’ sex, age, marital
status or education. Therefore, in order to support PE
and GSE, all patients need to be offered follow-up, and
we are inclined to say that it should be personalised,
with a focus on the patients’ beliefs, needs and goals.
Additional files
Additional file 1: Questionnaire measuring General Self-efficacy
(PDF 89 kb)
Additional file 2: Questionnaire measuring Self-rated health
(PDF 110 kb)
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